GlassScriptPhysician profile
Lisa Dawn Crough
NPI 1740222900
$4,032.02
in general payments reported to CMS, 2019-2025
19 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,756 · 2022: $797 · 2023: $514 · 2024: $712 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,478.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $1,054.60 | 2021-2024 | Carto 3, N/A |
| Abbott Laboratories | $621.99 | 2021-2025 | Jot Dx, Ensite, Optis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $592.87 | 2021-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $503.53 | 2021-2022 | |
| Medtronic, INC. | $455.47 | 2022-2025 | Resolute Onyx, Linq II, Micra |
| Novo Nordisk INC | $167.22 | 2023-2024 | Ozempic, Wegovy |
| Boston Scientific Corporation | $122.59 | 2021-2025 | Rotapro, Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.57 | 2021-2024 | Jardiance |
| Lantheus Medical Imaging, INC. | $94.73 | 2021-2023 | Definity |
| Astrazeneca Pharmaceuticals LP | $84.10 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $43.87 | 2022 | |
| Shockwave Medical, INC | $38.89 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $29.97 | 2021 | |
| Amgen INC. | $22.15 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.15 | 2024 | Eliquis |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $16.87 | 2023 | Sapien 3 Ultra Resilia |
| Astellas Pharma US INC | $15.79 | 2023 | Lexiscan |
| Cvrx, INC. | $15.63 | 2022 | |
| Terumo Medical Corporation | $14.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Crough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.